paraneoplastic syndrome

From Aaushi
Jump to navigation Jump to search

Introduction

Syndrome resulting from distant effects of a neoplasm.

Classification

* most common paraneoplastic syndromes

Etiology

  • cause of paraneoplastic syndromes is generally autoimmune

Clinical manifestations

Laboratory

More general terms

More specific terms

References

  1. Mayo Internal Medicine Board Review, 1998-99, Prakash UBS (ed) Lippincott-Raven, Philadelphia, 1998, pg 677-678
  2. Harrison's Principles of Internal Medicine, 14th ed. Fauci et al (eds), McGraw-Hill Inc. NY, 1998, pg 619, 621
  3. 3.0 3.1 Medical Knowledge Self Assessment Program (MKSAP) 15, 16, 17. American College of Physicians, Philadelphia 2009, 2012, 2015
  4. Pelosof LC, Gerber DE. Paraneoplastic syndromes: an approach to diagnosis and treatment. Mayo Clin Proc. 2010 Sep;85(9):838-54. PMID: https://www.ncbi.nlm.nih.gov/pubmed/20810794
  5. Titulaer MJ, Soffietti R, Dalmau J et al Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. Eur J Neurol. 2011 Jan;18(1):19-e3 PMID: https://www.ncbi.nlm.nih.gov/pubmed/20880069
  6. Vedeler CA, Antoine JC, Giometto B et al Management of paraneoplastic neurological syndromes: report of an EFNS Task Force. Eur J Neurol. 2006 Jul;13(7):682-90. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16834698
  7. Dimitriadis GK, Angelousi A, Weickert MO et al Paraneoplastic endocrine syndromes. Endocr Relat Cancer. 2017 Jun;24(6):R173-R190. PMID: https://www.ncbi.nlm.nih.gov/pubmed/28341725 Review.
  8. NINDS Paraneoplastic Syndromes Information Page https://www.ninds.nih.gov/disorders/all-disorders/paraneoplastic-syndromes-information-page

Patient information

paraneoplastic syndrome patient information